Authors:
AHMAD S
AHSAN A
IQBAL O
HOPPENSTEADT DA
LEWIS BE
WALENGA JM
FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULAR PATIENTS, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 243-249
Authors:
KAISER B
GLUSA E
HOPPENSTEADT DA
BREDDIN HK
AMIRAL J
FAREED J
Citation: B. Kaiser et al., A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (IK-SSH) INCREASES PLASMA-LEVELS OF FREE AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMANS, Blood coagulation & fibrinolysis, 9(6), 1998, pp. 517-523
Authors:
GEORGE M
HOPPENSTEADT DA
LIETZ H
AHMAD S
FAREED J
Citation: M. George et al., PERFORMANCE-CHARACTERISTICS OF 2 ELISA-BASED METHODS FOR THE QUANTITATION OF SOLUBLE THROMBOMODULIN IN PLASMA, The FASEB journal, 12(4), 1998, pp. 1114-1114
Authors:
AMIN HM
LIETZ H
HOPPENSTEADT DA
WALENGA JM
GEORGE M
AHMAD S
FAREED J
Citation: Hm. Amin et al., QUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA, The FASEB journal, 12(4), 1998, pp. 1115-1115
Authors:
AHMAD S
AHSAN A
IQBAL O
HOPPENSTEADT DA
LEWIS BE
WALENGA JM
FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS, The FASEB journal, 12(4), 1998, pp. 2368-2368
Authors:
FAREED J
CALLAS D
HOPPENSTEADT DA
WALENGA JM
BICK RL
Citation: J. Fareed et al., ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT, The Medical clinics of North America, 82(3), 1998, pp. 569
Authors:
FAREED J
HOPPENSTEADT DA
LEYA F
IQBAL O
WOLF H
BICK R
Citation: J. Fareed et al., USEFUL LABORATORY TESTS FOR STUDYING THROMBOGENESIS IN ACUTE CARDIAC SYNDROMES, Clinical chemistry, 44(8), 1998, pp. 1845-1853
Authors:
FAREED J
HOPPENSTEADT DA
JESKE W
AMIRAL J
WALENGA JM
Citation: J. Fareed et al., NON-HEPARIN GLYCOSAMINOGLYCANS-INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, Clinical chemistry, 44, 1998, pp. 212-212
Authors:
IQBAL O
AHMAD S
HOPPENSTEADT DA
LEWIS BE
FAREED J
Citation: O. Iqbal et al., SPECIFIC QUANTITATION OF THROMBIN INHIBITORS USING ECARIN CLOTTING TIME - APPLICATION IN POINT OF CARE TESTING, Clinical chemistry, 44, 1998, pp. 221-221
Authors:
AMIN HM
LIETZ H
HOPPENSTEADT DA
WALENGA JM
GEORGE M
AHMAD S
FAREED J
Citation: Hm. Amin et al., IMMUNOQUANTITATION OF SOLUBLE P-SELECTIN IN HUMAN PLASMA - EFFECT OF ANTICOAGULANT MATRIX AND PRELIMINARY CLINICAL-DATA, Clinical chemistry, 44, 1998, pp. 223-223
Authors:
GEORGE M
HOPPENSTEADT DA
LIETZ H
AHMAD S
AMIRAL J
FAREED J
Citation: M. George et al., STUDIES ON THE PERFORMANCE-CHARACTERISTICS OF 2 ELISA-BASED METHODS FOR THE QUANTITATION OF SOLUBLE THROMBOMODULIN IN PLASMA, Clinical chemistry, 44, 1998, pp. 228-228
Authors:
AHMAD S
AHSAN A
IQBAL O
HOPPENSTEADT DA
LEWIS BE
WALENGA JM
FAREED J
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A SYNTHETIC ANTITHROMBIN AGENT, ARGATROBAN, IN MAN AS STUDIED BY HPLC AND FUNCTIONAL METHODS - IMPLICATIONS IN THE MONITORING AND DOSAGE-OPTIMIZATIONS IN CARDIOVASCULARPATIENTS, Clinical chemistry, 44, 1998, pp. 229-229
Authors:
SHEIKH A
YANG LH
FU KD
HOPPENSTEADT DA
AHMAD S
FAREED J
Citation: A. Sheikh et al., MONITORING OF THE ANTIPLATELET EFFECT OF GP IIB IIIA INHIBITOR USING FROZEN PLATELET-POOR PLASMA COLLECTED AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN PRIMATES/, Clinical chemistry, 44, 1998, pp. 473-473
Citation: Da. Hoppensteadt et al., FACTOR-X VALUES AS A MEANS TO ASSESS THE EXTENT OF ORAL ANTICOAGULATION IN PATIENTS RECEIVING ANTITHROMBIN DRUGS, Clinical chemistry, 43(9), 1997, pp. 1786-1788
Authors:
KAISER B
GLUSA E
LIETZ H
HOPPENSTEADT DA
BREDDIN HK
AMIRAL J
FAREED J
Citation: B. Kaiser et al., A LOW-MOLECULAR-WEIGHT HYPERSULFATED HEPARIN DERIVATIVE WITH LOW ANTICOAGULANT ACTIVITY RELEASES VASCULAR TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - STUDIES ON TOTAL AND FREE TFPI, Blood, 90(10), 1997, pp. 3238-3238
Citation: Dg. Jacobs et al., HEMODYNAMIC AND FIBRINOLYTIC CONSEQUENCES OF INTERMITTENT PNEUMATIC COMPRESSION - PRELIMINARY-RESULTS, The journal of trauma, injury, infection, and critical care, 40(5), 1996, pp. 710-717
Citation: Dg. Jacobs et al., INTERMITTENT PNEUMATIC COMPRESSION AND FIBRINOLYSIS - DESCRIPTION OF A NEW MODEL, International angiology, 15(3), 1996, pp. 27-31
Authors:
HOPPENSTEADT DA
JESKE W
FAREED J
NICOLAIDES AN
Citation: Da. Hoppensteadt et al., PHYSICAL AND PHARMACOLOGICAL MANIPULATION OF THE VASCULAR SYSTEM AS MEASURED BY THE RELEASE OF TFPI AND OTHER MEDIATORS OF ANTITHROMBOTIC ACTIONS, International angiology, 15(1), 1996, pp. 39-46
Citation: Lh. Yang et al., DEFIBROTIDE MEDIATED INHIBITION OF SEROTONIN, ENDOTHELIN-I, THROMBOXANE, AND SERUM-INDUCED CONTRACTION OF CANINE FEMORAL AND PULMONARY ARTERIAL RINGS, Thrombosis research, 84(3), 1996, pp. 167-177
Authors:
FAREED J
WALENGA JM
JESKE W
KOZA MJ
HOPPENSTEADT DA
RAIBLE M
MESSMORE HL
BREDDIN K
Citation: J. Fareed et al., CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), Clinical chemistry, 42(6), 1996, pp. 223-223
Authors:
KAHN S
WOLF H
HOPPENSTEADT DA
WALENGA JM
GALBRAITH E
BERMES EW
FAREED J
Citation: S. Kahn et al., DIAGNOSTIC-VALUE OF TROPONIN-T AS A MARKER OF MYOCARDIAL INJURY IN ACUTE AND CHRONIC CORONARY SYNDROMES, Clinical chemistry, 42(6), 1996, pp. 330-330
Authors:
FASANELLA A
HOPPENSTEADT DA
WOLF H
BERMES EW
FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Clinical chemistry, 42(6), 1996, pp. 409-409
Authors:
KOZA MJ
HOPPENSTEADT DA
WALENGA JM
FAREED J
BERMES EW
PIFARRE R
Citation: Mj. Koza et al., EFFECT OF A GLYCOPROTEIN IIB IIIA INHIBITOR ON PLATELET ACTIVATION AND AGGREGATION AS MEASURED BY AGGREGOMETRY AND WHOLE-BLOOD FLOW-CYTOMETRY/, Clinical chemistry, 42(6), 1996, pp. 411-411